yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34023028-598E5584-D1D1-4DF0-813E-3B8A927CD312
Q34023028-598E5584-D1D1-4DF0-813E-3B8A927CD312
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34023028-598E5584-D1D1-4DF0-813E-3B8A927CD312
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.
P2860
Q34023028-598E5584-D1D1-4DF0-813E-3B8A927CD312
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34023028-598E5584-D1D1-4DF0-813E-3B8A927CD312
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be42c6bb59187110f4ae0ce045cd56ac1c4ff8fa
P2860
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.